Clinical trial · Interventional
Post Excision/Mohs Scar Laser Resurfacing
Post Excision/Mohs Fractional CO2 Resurfacing: A Quantitative and Qualitative Scar Analysis Study
NCT02130297CI-TRIAL-00051330completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the potential benefits of treating a surgical scar post excision with an ablative fractionated CO2 laser with the goal of decreasing the appearance and size of the scar.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Laser Treatment | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Group 1 - day 1
- description
- Group 1 will receive laser therapy to half of the scar the day of the excision.
- interventionNames
- Device: Laser Treatment
- type
- ACTIVE_COMPARATOR
- label
- Group 2 - day 14
- description
- Group 2 will receive laser therapy at the time of suture removal or post-operative day 14.
- interventionNames
- Device: Laser Treatment
- type
- ACTIVE_COMPARATOR
- label
- Group 3 - week 9
- description
- Group 3 will receive laser treatment to half the scar at the 9 week postop visit.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Must understand and voluntarily sign an informed consent form. * Must be male or female and aged \>18 years at the time of consent. * Must be able to adhere to the study visit schedule and other protocol requirements. * Patients undergoing skin excisions of the face/trunk/extremities. Exclusion Criteria: * Inability to provide voluntary informed consent * Use of laser or light based treatments to affected areas in past year * Fitzpatrick Skin types 3-5 * Surgical lesions located on the central chest * History of keloid formation * History of Accutane in the last six months
References
Publications (0)
Data not yet available
No reference posted for this study.